9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine

C23H21N5 — CID 118708357

IUPAC9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine
SMILESCc1cc2c3cnccc3cc(CCc3nc(-c4ccccc4)cn3C)n2n1
InChIInChI=1S/C23H21N5/c1-16-12-22-20-14-24-11-10-18(20)13-19(28(22)26-16)8-9-23-25-21(15-27(23)2)17-6-4-3-5-7-17/h3-7,10-15H,8-9H2,1-2H3
InChIKeySBLADHMPNVHYCB-UHFFFAOYSA-N
MW367.46 g/mol
LogP4.38
Rot. Bonds4

About 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine

9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine (PubChem CID 118708357) has the molecular formula C23H21N5 and a molecular weight of 367.46 g/mol. Its IUPAC name is 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine.

Molecular Properties

Compound Name9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine
PubChem CID118708357
Molecular FormulaC23H21N5
Molecular Weight367.46 g/mol
Exact Mass367.18
IUPAC Name9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine
SMILESCc1cc2c3cnccc3cc(CCc3nc(-c4ccccc4)cn3C)n2n1
InChIInChI=1S/C23H21N5/c1-16-12-22-20-14-24-11-10-18(20)13-19(28(22)26-16)8-9-23-25-21(15-27(23)2)17-6-4-3-5-7-17/h3-7,10-15H,8-9H2,1-2H3
InChIKeySBLADHMPNVHYCB-UHFFFAOYSA-N
XLogP4.38
TPSA48.01 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500367.46
LogP ≤ 54.38
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Imiquimod
CID 57469
Avapritinib
CID 118023034
Savolitinib
CID 68289010
Adipiplon
CID 11198924
Pf-04217903
CID 17754438
Tegobuvir
CID 23649154
6-(Difluoro(6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)methyl)quinoline
CID 46911863
Pf-05180999
CID 60143346
Vactosertib
CID 54766013
N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine
CID 6603857
Fazadinium Bromide
CID 6321422
FK-739 free acid
CID 9801627

Frequently Asked Questions

What is the IUPAC name of 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine?
The IUPAC name of 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine (CID 118708357) is 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine.
What is the SMILES notation for 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine?
The canonical SMILES for 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine is Cc1cc2c3cnccc3cc(CCc3nc(-c4ccccc4)cn3C)n2n1.
What is the InChIKey of 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine?
The InChIKey is SBLADHMPNVHYCB-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H21N5/c1-16-12-22-20-14-24-11-10-18(20)13-19(28(22)26-16)8-9-23-25-21(15-27(23)2)17-6-4-3-5-7-17/h3-7,10-15H,8-9H2,1-2H3.
What are the key properties of 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine?
9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine has a molecular weight of 367.46 g/mol, XLogP of 4.38, 4 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 9-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazolo[5,1-a][2,7]naphthyridine is sourced from PubChem (CID 118708357), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).